In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Spectrum Pharmaceuticals Inc.

http://www.sppirx.com/

Latest From Spectrum Pharmaceuticals Inc.

Bausch Investors Initially Pessimistic Following B+L Spinout

With its IPO of Bausch + Lomb bringing in $630m in proceeds, Bausch Health is moving forward with its plan to use the eye care unit’s separation to pay down its remaining debt.

Sales & Earnings Business Strategies

Bausch Hopes B+L Spin-Out Will 'Unlock' The Value Of Eye-Care Business

Bausch Health is paying down its debt with a $630m IPO for its Bausch + Lomb eyecare product business.

Sales & Earnings Business Strategies

Korea Q1 Roundup: Overseas Sales, COVID Prove Positive In Mixed Results

Among recent highlights, SK Bioscience files for approval of recombinant protein COVID-19 vaccine GBP510, Hanmi Pharmaceutical’s Chinese subsidiary continues to report strong earnings, led by cold drug sales, while Yuhan’s novel peptide drug candidate for degenerative disc disease is set to move into a Phase III trial in the US.

South Korea Sales & Earnings

Finance Watch: HilleVax, Belite Bio Launch First Two Biopharma IPOs In Q2

Also, Cytovia will go public via SPAC merger, Nkarta capitalized on its positive early NK cell therapy data with a $230m offering, and venture capital mega-rounds include $220m for Reify, $110m for Satellite Bio and $100m for OMass Therapeutics. 

Financing Innovation
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Allos Therapeutics, Inc.
    • OncoRx
    • Talon Therapeutics, Inc. (Hana Biosciences, Inc.)
UsernamePublicRestriction

Register